{
  "iteration": 88,
  "question_id": "index_87",
  "status": "SUCCESS",
  "n_chains_max": 16,
  "window_size": 2,
  "n_chains_generated": 2,
  "stopped_early": true,
  "correct_answer_reference": "A",
  "voted_answer": "A",
  "final_score": 1,
  "individual_answers": [
    "A",
    "A"
  ],
  "processing_duration_sec": 38.39633011817932,
  "usage_aggregated": {
    "prompt_tokens": 173,
    "total_completion_tokens": 3082,
    "total_tokens": 3255
  },
  "chains_details": [
    {
      "chain_index": 1,
      "reasoning_text": "Okay, let's tackle this question step by step. So the question is about a rotavirus study where the inner capsid proteins are tagged with GFP. The mice are given these proteins via oral gavage. They observed that some fluorescence was destroyed by stomach acid, and some got stuck in the intestinal mucus before reaching the secondary lymphoid organs. Then they looked at the Peyer patches, which are known to be part of the immune system in the intestines, right? They isolated the proliferating cells and found high variability in their variable heavy chain genes. The options are about different immune processes: somatic hypermutation, complement activation, class switching recombination, or VDJ recombination.\n\nHmm. First, I need to remember what each of these processes does. Let's start with Peyer patches. Those are part of the mucosal immune system, so they're involved in sampling antigens from the gut. The proteins (capsid) are acting as antigens here since they're tagged with GFP. The mice's immune system is responding to them.\n\nThe key part here is the high variability in the variable heavy chain genes. Variable regions are part of antibodies, which are made by B cells. The variable region is where the antigen-binding site is, and its diversity comes from gene rearrangement and mutation processes.\n\nVDJ recombination is the process that occurs in B cell development, where the V, D, and J gene segments are rearranged to form the variable region of the antibody. This happens early in B cell maturation, leading to a diverse set of B cell receptors (BCRs). So VDJ recombination would create the initial diversity.\n\nSomatic hypermutation (option A) is a process that occurs later, during the immune response, where the variable regions of the antibody genes undergo point mutations. This is to fine-tune the antibody's affinity for the antigen after an immune response is triggered. This leads to increased variability in the antibody repertoire, especially in cells that have been activated.\n\nClass switching recombination (option C) is when the class of the antibody (like IgM to IgG) is changed, but the variable region remains the same. So that's about the constant region, not the variable. So that's probably not the answer here since the question mentions variability in the variable region.\n\nComplement activation (option B) is part of the immune response but involves complement proteins, not directly related to the genetic variability in B cells. So that's probably not it.\n\nThe question states that they observed high variability in the variable heavy chain genes. So when does that happen? VDJ recombination creates the initial diversity, but somatic hypermutation adds more mutations to existing variable regions. The context here is that the cells are proliferating in the Peyer patches. Peyer patches are part of the secondary lymphoid organs, right? Wait, the question says the proteins were entangled in the intestinal mucus before reaching the secondary lymphoid organs. But the Peyer patches themselves are secondary lymphoid organs. So the cells in the Peyer patches would be undergoing the immune response.\n\nSo when B cells encounter antigen in the lymphoid organs, they can form germinal centers. In germinal centers, B cells undergo somatic hypermutation, leading to mutations in their variable regions. The cells that have higher affinity antibodies survive and proliferate. So the high variability in the variable genes would be due to somatic hypermutation. \n\nWait, but VDJ recombination happens earlier, during B cell development in the bone marrow. So when the B cells first mature, their VDJ regions are rearranged, but that's a one-time event. The somatic hypermutation happens later when they are activated in the lymph nodes or Peyer patches. Since the question mentions that the cells are proliferating and there's high variability in the variable regions, that points to somatic hypermutation (A) rather than VDJ recombination (D). \n\nTherefore, the answer should be A. Let me check again. The options: D is VDJ recombination. So VDJ is during B cell development, not during an active immune response's proliferation phase. The question's scenario is about an immune response to the antigen (the GFP-tagged proteins), so the process causing the variability here would be somatic hypermutation. Yeah, that makes sense. The high variability comes from mutations introduced during the immune response, not the initial rearrangement. So the answer is A.\n",
      "final_answer_text": "\n\nThe question involves an experiment where rotavirus capsid proteins tagged with GFP are administered to mice. The observed fluorescence destruction and entanglement in intestinal mucus suggest the proteins are acting as antigens. The identification of proliferating cells with high variability in variable heavy chain genes in Peyer patches (a secondary lymphoid organ) indicates an immune response. \n\n**Key points:**\n- **Peyer patches** are secondary lymphoid organs where B cells encounter antigens.\n- **Variable heavy chain variability** arises from processes that increase antibody diversity.\n- **VDJ recombination** occurs during B cell development in the bone marrow, creating initial diversity but not during an active immune response.\n- **Somatic hypermutation** occurs in activated B cells (e.g., in germinal centers) and introduces point mutations to refine antibody affinity, leading to high variability in the variable regions.\n- **Class switching recombination** alters antibody class (e.g., IgM to IgG) but does not affect variable regions.\n- **Complement activation** is unrelated to genetic variability in B cells.\n\nThe high variability observed in the variable regions during an active immune response in Peyer patches points to **somatic hypermutation**, which occurs as B cells proliferate and refine their antibodies. \n\nAnswer: A) somatic hypermutation.\n\nAnswer: A",
      "full_content": "Okay, let's tackle this question step by step. So the question is about a rotavirus study where the inner capsid proteins are tagged with GFP. The mice are given these proteins via oral gavage. They observed that some fluorescence was destroyed by stomach acid, and some got stuck in the intestinal mucus before reaching the secondary lymphoid organs. Then they looked at the Peyer patches, which are known to be part of the immune system in the intestines, right? They isolated the proliferating cells and found high variability in their variable heavy chain genes. The options are about different immune processes: somatic hypermutation, complement activation, class switching recombination, or VDJ recombination.\n\nHmm. First, I need to remember what each of these processes does. Let's start with Peyer patches. Those are part of the mucosal immune system, so they're involved in sampling antigens from the gut. The proteins (capsid) are acting as antigens here since they're tagged with GFP. The mice's immune system is responding to them.\n\nThe key part here is the high variability in the variable heavy chain genes. Variable regions are part of antibodies, which are made by B cells. The variable region is where the antigen-binding site is, and its diversity comes from gene rearrangement and mutation processes.\n\nVDJ recombination is the process that occurs in B cell development, where the V, D, and J gene segments are rearranged to form the variable region of the antibody. This happens early in B cell maturation, leading to a diverse set of B cell receptors (BCRs). So VDJ recombination would create the initial diversity.\n\nSomatic hypermutation (option A) is a process that occurs later, during the immune response, where the variable regions of the antibody genes undergo point mutations. This is to fine-tune the antibody's affinity for the antigen after an immune response is triggered. This leads to increased variability in the antibody repertoire, especially in cells that have been activated.\n\nClass switching recombination (option C) is when the class of the antibody (like IgM to IgG) is changed, but the variable region remains the same. So that's about the constant region, not the variable. So that's probably not the answer here since the question mentions variability in the variable region.\n\nComplement activation (option B) is part of the immune response but involves complement proteins, not directly related to the genetic variability in B cells. So that's probably not it.\n\nThe question states that they observed high variability in the variable heavy chain genes. So when does that happen? VDJ recombination creates the initial diversity, but somatic hypermutation adds more mutations to existing variable regions. The context here is that the cells are proliferating in the Peyer patches. Peyer patches are part of the secondary lymphoid organs, right? Wait, the question says the proteins were entangled in the intestinal mucus before reaching the secondary lymphoid organs. But the Peyer patches themselves are secondary lymphoid organs. So the cells in the Peyer patches would be undergoing the immune response.\n\nSo when B cells encounter antigen in the lymphoid organs, they can form germinal centers. In germinal centers, B cells undergo somatic hypermutation, leading to mutations in their variable regions. The cells that have higher affinity antibodies survive and proliferate. So the high variability in the variable genes would be due to somatic hypermutation. \n\nWait, but VDJ recombination happens earlier, during B cell development in the bone marrow. So when the B cells first mature, their VDJ regions are rearranged, but that's a one-time event. The somatic hypermutation happens later when they are activated in the lymph nodes or Peyer patches. Since the question mentions that the cells are proliferating and there's high variability in the variable regions, that points to somatic hypermutation (A) rather than VDJ recombination (D). \n\nTherefore, the answer should be A. Let me check again. The options: D is VDJ recombination. So VDJ is during B cell development, not during an active immune response's proliferation phase. The question's scenario is about an immune response to the antigen (the GFP-tagged proteins), so the process causing the variability here would be somatic hypermutation. Yeah, that makes sense. The high variability comes from mutations introduced during the immune response, not the initial rearrangement. So the answer is A.\n\n\nThe question involves an experiment where rotavirus capsid proteins tagged with GFP are administered to mice. The observed fluorescence destruction and entanglement in intestinal mucus suggest the proteins are acting as antigens. The identification of proliferating cells with high variability in variable heavy chain genes in Peyer patches (a secondary lymphoid organ) indicates an immune response. \n\n**Key points:**\n- **Peyer patches** are secondary lymphoid organs where B cells encounter antigens.\n- **Variable heavy chain variability** arises from processes that increase antibody diversity.\n- **VDJ recombination** occurs during B cell development in the bone marrow, creating initial diversity but not during an active immune response.\n- **Somatic hypermutation** occurs in activated B cells (e.g., in germinal centers) and introduces point mutations to refine antibody affinity, leading to high variability in the variable regions.\n- **Class switching recombination** alters antibody class (e.g., IgM to IgG) but does not affect variable regions.\n- **Complement activation** is unrelated to genetic variability in B cells.\n\nThe high variability observed in the variable regions during an active immune response in Peyer patches points to **somatic hypermutation**, which occurs as B cells proliferate and refine their antibodies. \n\nAnswer: A) somatic hypermutation.\n\nAnswer: A",
      "logprobs": null,
      "finish_reason": "stop",
      "completion_tokens": 1177,
      "prompt_tokens": 173,
      "usage": {
        "prompt_tokens": 173,
        "total_tokens": 1350,
        "completion_tokens": 1177
      },
      "extracted_answer": "A"
    },
    {
      "chain_index": 2,
      "reasoning_text": "Okay, let's see. The question is about a science experiment with rotavirus and mice. The main point is figuring out which process is happening based on the observations.\n\nSo, the setup is that they tagged the inner capsid proteins of rotavirus with GFP and gave them to mice via oral gavage. Then they used in vivo imaging. Some fluorescence was destroyed by stomach acid, which makes sense because stomach acid is harsh. Others got stuck in the intestinal mucus before reaching the secondary lymphoid organs. Then they looked at the Peyer patches, which I remember are part of the immune system in the intestines, right? They isolated the proliferating cells and sequenced the variable heavy chain genes, finding high variability. The question is asking which process is happening here.\n\nThe options are somatic hypermutation, complement activation, class switching recombination, or VDJ recombination.\n\nHmm. Let's break down each part. The key here is the high variability in the variable heavy chain genes. Variable heavy chains are part of antibodies, so this is about B cells. \n\nSomatic hypermutation occurs in already formed B cells during an immune response, causing mutations in the antibody genes to improve affinity. That leads to increased variability. But when does this happen? It's in the germinal centers, part of the adaptive immune response. \n\nVDJ recombination is the process where the T and B cells assemble their antigen receptors. That happens during B cell development in the bone marrow. The V, D, and J gene segments combine to make the variable regions. So that's the initial rearrangement to create diverse receptors. \n\nClass switching recombination changes the class of the antibody (like from IgM to IgG) without changing the antigen specificity. That's another process in B cells after they've been activated. \n\nComplement activation is part of the innate immune system, involving complement proteins, so probably not related here since the question is about genetic variability in B cells.\n\nThe experiment's setup: the proteins are delivered orally, so they're entering through the gut. Peyer's patches are part of the mucosal immune system, where B cells would encounter antigens. The proliferating cells in Peyer's patches would be B cells undergoing some process. \n\nThe variable heavy chain genes having high variability suggests that the B cells are generating a lot of different antibodies. If this is during the initial encounter with the antigen, maybe it's VDJ recombination. Wait, but VDJ happens during B cell maturation in the bone marrow. Alternatively, if the B cells have already been activated, maybe somatic hypermutation is causing the variability. \n\nWait, the question says they observed the proliferating cells in the Peyer patches. Proliferation suggests active cell division. Somatic hypermutation occurs in germinal centers, which are in lymph nodes, not sure about Peyer's patches. But Peyer's patches are part of the lymphoid organs. \n\nAlternatively, when B cells first encounter antigen, they might start proliferating and undergo somatic hypermutation. Wait, but VDJ recombination is the initial step to generate diversity. If the variable regions are showing high variability, maybe that's the result of the initial rearrangement. But the question is about the process taking place when they sequenced the proliferating cells. \n\nWait, the proteins are being presented, so maybe the B cells are being activated. The variable regions would have already been rearranged (VDJ) during their development. But if they are in Peyer's patches and proliferating, perhaps they are undergoing somatic hypermutation as part of the adaptive response. \n\nWait, somatic hypermutation occurs in activated B cells in germinal centers, leading to mutations in the variable regions to improve binding. The high variability in the variable heavy chain genes would fit with that. \n\nAlternatively, VDJ recombination is when the genes are first rearranged to make the initial diversity. So if the cells are in the Peyer patches, maybe the B cells are just developing there, but I thought B cells are developed in the bone marrow. \n\nHmm. Let me think again. The process that creates the variable regions is VDJ recombination. That's during B cell development. But once they're in the periphery, like in the Peyer's patches, if they encounter an antigen, they might start to proliferate. The high variability in the variable regions could be due to somatic hypermutation if they're in germinal centers. \n\nWait, but the question states that the cells are proliferating. Somatic hypermutation occurs in the germinal centers where B cells proliferate. So if the cells are in the Peyer's patches and proliferating, and their variable regions have high variability, then somatic hypermutation (option A) is the process. \n\nBut another thought: when B cells first recognize an antigen, their BCR (which was made via VDJ) is specific. But the question says the variable genes have high variability. So maybe the initial VDJ recombination is what caused the diversity. But that would have happened before they even encountered the antigen, right? \n\nWait, the variable regions are already formed via VDJ. But if they are now undergoing somatic hypermutation, that would introduce more variability. So the high variability in the variable heavy chains here would be from somatic hypermutation. \n\nAlternatively, maybe the process is VDJ recombination. But VDJ happens in the bone marrow, not in the Peyer's patches. Unless the question is considering that some B cells are still undergoing recombination there, but I don't think so. \n\nSo the options are between A and D. \n\nWait, the question says \"they observe high variability\". The process that's happening now is the one causing that variability. \n\nVDJ recombination is the initial rearrangement, which creates the diversity of BCRs. So each B cell has a unique rearrangement. But if you sequence the variable regions of a population of B cells, you would already see variability because each has a different rearrangement. But in this case, the question states that after the experiment, when they look at the proliferating cells, the variability is high. \n\nWait, perhaps the key is that the variable regions are being mutated further. Somatic hypermutation is the process that introduces point mutations in the variable regions to increase affinity. So if the cells are in the Peyer's patches and proliferating (so in germinal centers), then the high variability is due to somatic hypermutation. \n\nTherefore, the answer should be A) somatic hypermutation. \n\nAlternatively, if the B cells are just being activated and starting to proliferate, but not yet in germinal centers, then maybe the variability is from the initial VDJ. But in that case, the variability would already be there. The question says they observed high variability upon sequencing, which might be a result of the process happening there. \n\nHmm. Wait, the variable regions have already been formed through VDJ recombination. The high variability in their sequences when they are isolated from the Peyer's patches would be because each B cell has a different VDJ combination, but that's the normal diversity. However, if they are in the process of somatic hypermutation, then the variability would increase further. \n\nThe question states that the variable heavy chain genes show high variability. Since somatic hypermutation increases mutations in the variable regions to generate more diversity, that would lead to higher variability. So if the cells are in the proliferating phase (germinal center), then somatic hypermutation is the process. \n\nTherefore, the correct answer is A. \n\nWait, but another angle: the process that assembles the variable regions is VDJ recombination. If the B cells are in the Peyer's patches and undergoing VDJ recombination, that would be the process. But VDJ occurs during B cell development in the bone marrow, not in the periphery. So that's probably not the case. \n\nTherefore, the answer must be A, somatic hypermutation.\n",
      "final_answer_text": "\n\nThe experiment involves oral delivery of GFP-tagged rotavirus proteins to mice, with imaging showing fluorescence destruction by stomach acid and entanglement in intestinal mucus. Fluorescent Peyer patches (part of the mucosal immune system) were analyzed, and proliferating cells showed high variability in their variable heavy chain genes. \n\nKey considerations:\n- **Peyer patches** are lymphoid tissues where B cells encounter antigens.\n- **Proliferating cells** suggest active immune response, such as in germinal centers.\n- **High variability in variable heavy chain genes** indicates ongoing genetic changes in B cells.\n\n**Somatic hypermutation** (A) occurs in germinal centers, introducing point mutations in antibody genes to enhance antigen affinity, leading to increased variability. This aligns with the observed proliferating cells in lymphoid organs and the high variability in variable regions.\n\n**VDJ recombination** (D) creates initial diversity during B cell development in the bone marrow, not in peripheral tissues like Peyer patches. **Class switching** (C) changes antibody isotypes without affecting variable regions. **Complement activation** (B) is unrelated to genetic variability in B cells.\n\nThus, the process causing the observed variability is **somatic hypermutation**.\n\nAnswer: A",
      "full_content": "Okay, let's see. The question is about a science experiment with rotavirus and mice. The main point is figuring out which process is happening based on the observations.\n\nSo, the setup is that they tagged the inner capsid proteins of rotavirus with GFP and gave them to mice via oral gavage. Then they used in vivo imaging. Some fluorescence was destroyed by stomach acid, which makes sense because stomach acid is harsh. Others got stuck in the intestinal mucus before reaching the secondary lymphoid organs. Then they looked at the Peyer patches, which I remember are part of the immune system in the intestines, right? They isolated the proliferating cells and sequenced the variable heavy chain genes, finding high variability. The question is asking which process is happening here.\n\nThe options are somatic hypermutation, complement activation, class switching recombination, or VDJ recombination.\n\nHmm. Let's break down each part. The key here is the high variability in the variable heavy chain genes. Variable heavy chains are part of antibodies, so this is about B cells. \n\nSomatic hypermutation occurs in already formed B cells during an immune response, causing mutations in the antibody genes to improve affinity. That leads to increased variability. But when does this happen? It's in the germinal centers, part of the adaptive immune response. \n\nVDJ recombination is the process where the T and B cells assemble their antigen receptors. That happens during B cell development in the bone marrow. The V, D, and J gene segments combine to make the variable regions. So that's the initial rearrangement to create diverse receptors. \n\nClass switching recombination changes the class of the antibody (like from IgM to IgG) without changing the antigen specificity. That's another process in B cells after they've been activated. \n\nComplement activation is part of the innate immune system, involving complement proteins, so probably not related here since the question is about genetic variability in B cells.\n\nThe experiment's setup: the proteins are delivered orally, so they're entering through the gut. Peyer's patches are part of the mucosal immune system, where B cells would encounter antigens. The proliferating cells in Peyer's patches would be B cells undergoing some process. \n\nThe variable heavy chain genes having high variability suggests that the B cells are generating a lot of different antibodies. If this is during the initial encounter with the antigen, maybe it's VDJ recombination. Wait, but VDJ happens during B cell maturation in the bone marrow. Alternatively, if the B cells have already been activated, maybe somatic hypermutation is causing the variability. \n\nWait, the question says they observed the proliferating cells in the Peyer patches. Proliferation suggests active cell division. Somatic hypermutation occurs in germinal centers, which are in lymph nodes, not sure about Peyer's patches. But Peyer's patches are part of the lymphoid organs. \n\nAlternatively, when B cells first encounter antigen, they might start proliferating and undergo somatic hypermutation. Wait, but VDJ recombination is the initial step to generate diversity. If the variable regions are showing high variability, maybe that's the result of the initial rearrangement. But the question is about the process taking place when they sequenced the proliferating cells. \n\nWait, the proteins are being presented, so maybe the B cells are being activated. The variable regions would have already been rearranged (VDJ) during their development. But if they are in Peyer's patches and proliferating, perhaps they are undergoing somatic hypermutation as part of the adaptive response. \n\nWait, somatic hypermutation occurs in activated B cells in germinal centers, leading to mutations in the variable regions to improve binding. The high variability in the variable heavy chain genes would fit with that. \n\nAlternatively, VDJ recombination is when the genes are first rearranged to make the initial diversity. So if the cells are in the Peyer patches, maybe the B cells are just developing there, but I thought B cells are developed in the bone marrow. \n\nHmm. Let me think again. The process that creates the variable regions is VDJ recombination. That's during B cell development. But once they're in the periphery, like in the Peyer's patches, if they encounter an antigen, they might start to proliferate. The high variability in the variable regions could be due to somatic hypermutation if they're in germinal centers. \n\nWait, but the question states that the cells are proliferating. Somatic hypermutation occurs in the germinal centers where B cells proliferate. So if the cells are in the Peyer's patches and proliferating, and their variable regions have high variability, then somatic hypermutation (option A) is the process. \n\nBut another thought: when B cells first recognize an antigen, their BCR (which was made via VDJ) is specific. But the question says the variable genes have high variability. So maybe the initial VDJ recombination is what caused the diversity. But that would have happened before they even encountered the antigen, right? \n\nWait, the variable regions are already formed via VDJ. But if they are now undergoing somatic hypermutation, that would introduce more variability. So the high variability in the variable heavy chains here would be from somatic hypermutation. \n\nAlternatively, maybe the process is VDJ recombination. But VDJ happens in the bone marrow, not in the Peyer's patches. Unless the question is considering that some B cells are still undergoing recombination there, but I don't think so. \n\nSo the options are between A and D. \n\nWait, the question says \"they observe high variability\". The process that's happening now is the one causing that variability. \n\nVDJ recombination is the initial rearrangement, which creates the diversity of BCRs. So each B cell has a unique rearrangement. But if you sequence the variable regions of a population of B cells, you would already see variability because each has a different rearrangement. But in this case, the question states that after the experiment, when they look at the proliferating cells, the variability is high. \n\nWait, perhaps the key is that the variable regions are being mutated further. Somatic hypermutation is the process that introduces point mutations in the variable regions to increase affinity. So if the cells are in the Peyer's patches and proliferating (so in germinal centers), then the high variability is due to somatic hypermutation. \n\nTherefore, the answer should be A) somatic hypermutation. \n\nAlternatively, if the B cells are just being activated and starting to proliferate, but not yet in germinal centers, then maybe the variability is from the initial VDJ. But in that case, the variability would already be there. The question says they observed high variability upon sequencing, which might be a result of the process happening there. \n\nHmm. Wait, the variable regions have already been formed through VDJ recombination. The high variability in their sequences when they are isolated from the Peyer's patches would be because each B cell has a different VDJ combination, but that's the normal diversity. However, if they are in the process of somatic hypermutation, then the variability would increase further. \n\nThe question states that the variable heavy chain genes show high variability. Since somatic hypermutation increases mutations in the variable regions to generate more diversity, that would lead to higher variability. So if the cells are in the proliferating phase (germinal center), then somatic hypermutation is the process. \n\nTherefore, the correct answer is A. \n\nWait, but another angle: the process that assembles the variable regions is VDJ recombination. If the B cells are in the Peyer's patches and undergoing VDJ recombination, that would be the process. But VDJ occurs during B cell development in the bone marrow, not in the periphery. So that's probably not the case. \n\nTherefore, the answer must be A, somatic hypermutation.\n\n\nThe experiment involves oral delivery of GFP-tagged rotavirus proteins to mice, with imaging showing fluorescence destruction by stomach acid and entanglement in intestinal mucus. Fluorescent Peyer patches (part of the mucosal immune system) were analyzed, and proliferating cells showed high variability in their variable heavy chain genes. \n\nKey considerations:\n- **Peyer patches** are lymphoid tissues where B cells encounter antigens.\n- **Proliferating cells** suggest active immune response, such as in germinal centers.\n- **High variability in variable heavy chain genes** indicates ongoing genetic changes in B cells.\n\n**Somatic hypermutation** (A) occurs in germinal centers, introducing point mutations in antibody genes to enhance antigen affinity, leading to increased variability. This aligns with the observed proliferating cells in lymphoid organs and the high variability in variable regions.\n\n**VDJ recombination** (D) creates initial diversity during B cell development in the bone marrow, not in peripheral tissues like Peyer patches. **Class switching** (C) changes antibody isotypes without affecting variable regions. **Complement activation** (B) is unrelated to genetic variability in B cells.\n\nThus, the process causing the observed variability is **somatic hypermutation**.\n\nAnswer: A",
      "logprobs": null,
      "finish_reason": "stop",
      "completion_tokens": 1905,
      "prompt_tokens": 173,
      "usage": {
        "prompt_tokens": 173,
        "total_tokens": 2078,
        "completion_tokens": 1905
      },
      "extracted_answer": "A"
    }
  ],
  "avg_kv_cache_usage": 0.005689181953664903,
  "max_kv_cache_usage": 0.0096337960746768
}